^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    narazaciclib (HX301)

    i
    Company:
    HanX Biopharma, Traws Pharma
    Drug class:
    CDK4/6 inhibitor, CSF-1R inhibitor, ARK5 inhibitor
    Related drugs:
    Apply
    Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies (NCT05705505)
    Phase 1/2
    Onconova Therapeutics, Inc.
    Recruiting
    Last update posted :
    12/12/2023
    Initiation :
    03/29/2023
    Primary completion :
    01/01/2026
    Completion :
    02/01/2026
    PGR
    |
    MSI-H/dMMR
    |
    letrozole • narazaciclib (HX301)
    The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors (NCT05731934)
    Phase 1
    Hangzhou Hanx Biopharmaceuticals, Ltd.
    Active, not recruiting
    Last update posted :
    09/22/2023
    Initiation :
    09/15/2020
    Primary completion :
    12/30/2023
    Completion :
    03/28/2024
    PD-L1
    |
    narazaciclib (HX301)